Intravenous Odatroltide for Acute Ischemic Stroke Within 24 Hours of Onset: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.

Published in: Drug design, development and therapy (2024)

Clinicaltrials.gov identifier: NCT04091945.

Keyphrases